| Pharmacokinetics and dosage adjustment in patients with hepatic dysfunction. RK Verbeeck Eur J Clin Phamacology. 64, 1147-1161, 2008 | 742 | 2008 |
| Pharmacokinetics and dosage adjustment in patients with renal dysfunction RK Verbeeck, FT Musuamba European journal of clinical pharmacology 65 (8), 757-773, 2009 | 360 | 2009 |
| Clinical pharmacokinetics of non-steroidal anti-inflammatory drugs RK Verbeeck, JL Blackburn, GR Loewen Clinical pharmacokinetics 8, 297-331, 1983 | 282 | 1983 |
| Comparative clinical pharmacokinetics of tacrolimus in paediatric and adult patients PE Wallemacq, RK Verbeeck Clinical pharmacokinetics 40, 283-295, 2001 | 198 | 2001 |
| Plasma protein binding of drugs in the elderly SM Wallace, RK Verbeeck Clinical pharmacokinetics 12, 41-72, 1987 | 170 | 1987 |
| Effect of age and sex on the plasma binding of acidic and basic drugs RK Verbeeck, JA Cardinal, SM Wallace European journal of clinical pharmacology 27, 91-97, 1984 | 158 | 1984 |
| Pharmacokinetic drug interactions with nonsteroidal anti-inflammatory drugs RK Verbeeck Clinical pharmacokinetics 19, 44-66, 1990 | 132 | 1990 |
| Systemic delivery of parathyroid hormone (1-34) using inhalation dry powders in rats V Codrons, F Vanderbist, RK Verbeeck, M Arras, D Lison, V Préat, ... Journal of pharmaceutical sciences 92 (5), 938-950, 2003 | 131 | 2003 |
| Extrahepatic glucuronidation of propofol in man: possible contribution of gut wall and kidney AA Raoof, LJ Van Obbergh, JV De Goyet, RK Verbeeck European journal of clinical pharmacology 50, 91-96, 1996 | 122 | 1996 |
| Generic substitution: the use of medicinal products containing different salts and implications for safety and efficacy RK Verbeeck, I Kanfer, RB Walker European journal of pharmaceutical sciences 28 (1-2), 1-6, 2006 | 119 | 2006 |
| Blood microdialysis in pharmacokinetic and drug metabolism studies RK Verbeeck Advanced drug delivery reviews 45 (2-3), 217-228, 2000 | 118 | 2000 |
| The effect of ageing on cytochrome p450 enzymes: consequences for drug biotransformation in the elderly V Wauthier, RK Verbeeck, P Buc Calderon Current medicinal chemistry 14 (7), 745-757, 2007 | 109 | 2007 |
| Effects of age and sex on piroxicam disposition CJ Richardson, KLN Blocka, SG Ross, RK Verbeeck Clinical Pharmacology & Therapeutics 37 (1), 13-18, 1985 | 102 | 1985 |
| Role of taurine in osmoregulation during endurance exercise C Cuisinier, J Michotte de Welle, RK Verbeeck, JR Poortmans, R Ward, ... European journal of applied physiology 87, 489-495, 2002 | 86 | 2002 |
| Effect of hepatic insufficiency on pharmacokinetics and drug dosing RK Verbeeck, Y Horsmans Pharmacy World and Science 20, 183-192, 1998 | 83 | 1998 |
| Optimizing treatment outcome of first-line anti-tuberculosis drugs: the role of therapeutic drug monitoring RK Verbeeck, G Günther, D Kibuule, C Hunter, TW Rennie European journal of clinical pharmacology 72, 905-916, 2016 | 81 | 2016 |
| Biotransformation of diflunisal and renal excretion of its glucuronides in renal insufficiency R Verbeeck, TB Tjandramaga, A Mullie, R Verbesselt, R Verberckmoes, ... British Journal of Clinical Pharmacology 7 (3), 273, 1979 | 80 | 1979 |
| Application of dermal microdialysis for the evaluation of bioequivalence of a ketoprofen topical gel RNO Tettey-Amlalo, I Kanfer, MF Skinner, E Benfeldt, RK Verbeeck european journal of pharmaceutical sciences 36 (2-3), 219-225, 2009 | 79 | 2009 |
| Biowaiver monographs for immediate release solid oral dosage forms based on biopharmaceutics classification system (BCS) literature data: Chloroquine phosphate, chloroquine … RK Verbeeck, HE Junginger, KK Midha, VP Shah, DM Barends Journal of pharmaceutical sciences 94 (7), 1389-1395, 2005 | 79 | 2005 |
| Biotransformation and excretion of lorazepam in patients with chronic renal failure R Verbeeck, TB Tjandramaga, R Verberckmoes, PJ De Schepper British Journal of Clinical Pharmacology 3 (6), 1033, 1976 | 74 | 1976 |
